BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1553964)

  • 1. Granulocyte-macrophage colony-stimulating factor for the treatment of neutropenia associated with large granular lymphocytic leukemia.
    Folk SM; Tefferi A
    Am J Hematol; 1992 Apr; 39(4):316. PubMed ID: 1553964
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease.
    Starkebaum G
    Curr Opin Hematol; 1997 May; 4(3):196-9. PubMed ID: 9209836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful short-term treatment with granulocyte-macrophage colony-stimulating factor of neutropenia due to cytotoxic chemotherapy of chronic lymphocytic leukemia.
    Rave K; Brittinger G
    Ann Hematol; 1991 Dec; 63(6):333. PubMed ID: 1756194
    [No Abstract]   [Full Text] [Related]  

  • 4. Etiology of neutrophilic granulocytic hypoplasia in a case of large granular lymphocytic leukemia with paraproteinemia.
    Friedman HD; Goldberg J; Kurec AS; Davey FR
    Med Pediatr Oncol; 1994; 23(6):503-6. PubMed ID: 7935178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome.
    Markusse HM; Breedveld FC; Fibbe WE
    Arthritis Rheum; 1990 Dec; 33(12):1865-7. PubMed ID: 2261008
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of granulocyte-macrophage colony-stimulating factor to enhance hematologic parameters of patients with cirrhosis and hypersplenism.
    Gurakar A; Fagiuoli S; Gavaler JS; Hassanein T; Jabbour N; Wright HI; Deal SA; Shah A; Brown M; Carr BI
    J Hepatol; 1994 Oct; 21(4):582-6. PubMed ID: 7814805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor in neutropenia.
    Hogan KR; Peters MD
    DICP; 1991 Jan; 25(1):32-5. PubMed ID: 2008785
    [No Abstract]   [Full Text] [Related]  

  • 8. [rhG-CSF treatment in cyclic neutropenia. Continuous versus intermittent rhG-CSF treatment in cyclic neutropenia].
    Nielsen H; Hansen PB
    Ugeskr Laeger; 1994 Jan; 156(3):324-5. PubMed ID: 8296427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia.
    Loughran TP; Kadin ME; Starkebaum G; Abkowitz JL; Clark EA; Disteche C; Lum LG; Slichter SJ
    Ann Intern Med; 1985 Feb; 102(2):169-75. PubMed ID: 3966754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia.
    Ray M; Mukhopadhyay K; Narang A
    Indian J Pediatr; 2000 Jan; 67(1):67-8. PubMed ID: 10832225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
    Ottmann OG; Bug G; Krauter J
    Semin Hematol; 2007 Jul; 44(3):183-92. PubMed ID: 17631182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of infections in patients with neutropenia (a review of the literature with the inclusion of the authors' own data)].
    Ptushkin VV; Bagirova NS; Volkova MA
    Ter Arkh; 1998; 70(7):83-7. PubMed ID: 9742648
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical features in large granular lymphocytic leukemia.
    Loughran TP; Starkebaum G
    Blood; 1987 Jun; 69(6):1786. PubMed ID: 3580580
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of clinical indolent natural killer cell lineage large granular lymphocytic leukemia in a patient with rheumatoid arthritis.
    Machatschek JN; Westerman D; Prince HM; Seymour JF
    Leuk Lymphoma; 2003 Jul; 44(7):1223-7. PubMed ID: 12916876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 viraemia during granulocyte-macrophage colony stimulating factor therapy.
    Lafeuillade A; Tamalet C; Pellegrino P; Tourres C; Vignoli C; Quilichini R
    AIDS; 1992 Dec; 6(12):1550-1. PubMed ID: 1492942
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
    Morstyn G; Sheridan W; Lieschke G; Cebon J; Layton J; Fox R
    Prog Clin Biol Res; 1990; 354B():29-36. PubMed ID: 1700441
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
    Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
    J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute myeloic leukemia: evaluation of colony-stimulating factors].
    Hiddemann W
    Dtsch Med Wochenschr; 2012 Nov; 137(45):2306. PubMed ID: 23111791
    [No Abstract]   [Full Text] [Related]  

  • 19. [First experience with the use of granulocyte-macrophage colony stimulating factor in pediatric oncology].
    Ferencz T; Csáki C; Koós R; Schuler D; Borsi J
    Orv Hetil; 1993 Jul; 134(27):1469-73. PubMed ID: 8351131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic growth factors in rheumatoid arthritis: a critical approach to their use in view of possible adverse effects.
    Vreugdenhil G; Schattenberg A; Dompeling EC; Swaak AJ; De Witte T
    Am J Med; 1993 Feb; 94(2):229-31. PubMed ID: 7679247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.